Robert Ryu
Concepts (501)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 24 | 2023 | 64 | 6.390 |
Why?
| | Embolization, Therapeutic | 44 | 2020 | 242 | 3.270 |
Why?
| | Liver Neoplasms | 60 | 2014 | 741 | 3.180 |
Why?
| | Device Removal | 18 | 2023 | 141 | 3.130 |
Why?
| | Yttrium Radioisotopes | 40 | 2020 | 63 | 2.830 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 10 | 2021 | 38 | 2.810 |
Why?
| | Carcinoma, Hepatocellular | 41 | 2014 | 353 | 2.490 |
Why?
| | Radiology, Interventional | 6 | 2024 | 34 | 2.460 |
Why?
| | Pulmonary Embolism | 11 | 2021 | 239 | 1.840 |
Why?
| | Radiography, Interventional | 17 | 2016 | 122 | 1.620 |
Why?
| | Esophageal and Gastric Varices | 4 | 2021 | 35 | 1.510 |
Why?
| | Chemoembolization, Therapeutic | 21 | 2014 | 88 | 1.470 |
Why?
| | Hypertension, Portal | 5 | 2016 | 64 | 1.300 |
Why?
| | Radiopharmaceuticals | 19 | 2020 | 188 | 1.280 |
Why?
| | Lumbar Vertebrae | 4 | 2021 | 251 | 1.230 |
Why?
| | Uterine Neoplasms | 11 | 2010 | 92 | 1.120 |
Why?
| | Vena Cava, Inferior | 7 | 2021 | 74 | 1.020 |
Why?
| | Educational Measurement | 2 | 2020 | 319 | 1.010 |
Why?
| | Venous Thrombosis | 6 | 2023 | 192 | 0.970 |
Why?
| | Lasers, Excimer | 2 | 2022 | 29 | 0.930 |
Why?
| | Renal Dialysis | 2 | 2020 | 457 | 0.900 |
Why?
| | Treatment Outcome | 71 | 2023 | 11182 | 0.900 |
Why?
| | Portal Vein | 4 | 2016 | 109 | 0.890 |
Why?
| | Practice Patterns, Physicians' | 9 | 2021 | 1344 | 0.880 |
Why?
| | Microspheres | 29 | 2013 | 142 | 0.870 |
Why?
| | Prosthesis Design | 7 | 2020 | 339 | 0.830 |
Why?
| | Magnetic Resonance Imaging, Interventional | 8 | 2014 | 26 | 0.800 |
Why?
| | Specialty Boards | 2 | 2020 | 39 | 0.790 |
Why?
| | Leiomyoma | 9 | 2007 | 56 | 0.790 |
Why?
| | Total Disc Replacement | 2 | 2020 | 14 | 0.770 |
Why?
| | Intervertebral Disc | 3 | 2020 | 37 | 0.760 |
Why?
| | Postoperative Complications | 8 | 2021 | 2821 | 0.750 |
Why?
| | Uterus | 7 | 2007 | 222 | 0.750 |
Why?
| | End Stage Liver Disease | 2 | 2021 | 76 | 0.750 |
Why?
| | Forecasting | 1 | 2024 | 384 | 0.740 |
Why?
| | Venous Insufficiency | 3 | 2007 | 12 | 0.710 |
Why?
| | Saphenous Vein | 3 | 2007 | 36 | 0.690 |
Why?
| | Thromboembolism | 3 | 2017 | 118 | 0.680 |
Why?
| | Middle Aged | 87 | 2026 | 34663 | 0.660 |
Why?
| | Spinal Fusion | 3 | 2021 | 259 | 0.640 |
Why?
| | Medicare | 3 | 2020 | 808 | 0.640 |
Why?
| | Humans | 152 | 2026 | 141767 | 0.640 |
Why?
| | Prosthesis Implantation | 3 | 2017 | 157 | 0.620 |
Why?
| | Intervertebral Disc Displacement | 1 | 2020 | 41 | 0.620 |
Why?
| | Laser Therapy | 3 | 2007 | 128 | 0.620 |
Why?
| | Diagnostic Imaging | 4 | 2024 | 327 | 0.620 |
Why?
| | Cerebrospinal Fluid Leak | 1 | 2020 | 68 | 0.600 |
Why?
| | Graft Occlusion, Vascular | 2 | 2018 | 39 | 0.580 |
Why?
| | Endovascular Procedures | 5 | 2020 | 356 | 0.580 |
Why?
| | Medicine | 1 | 2020 | 125 | 0.580 |
Why?
| | Magnetic Resonance Angiography | 10 | 2014 | 249 | 0.580 |
Why?
| | Low Back Pain | 1 | 2020 | 108 | 0.570 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 19 | 0.550 |
Why?
| | Venous Thromboembolism | 4 | 2017 | 337 | 0.540 |
Why?
| | Ultrasonography, Interventional | 3 | 2016 | 155 | 0.540 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 3 | 2019 | 213 | 0.540 |
Why?
| | Spine | 1 | 2019 | 180 | 0.530 |
Why?
| | Female | 103 | 2026 | 75957 | 0.530 |
Why?
| | Time Factors | 25 | 2021 | 6967 | 0.520 |
Why?
| | Magnetic Resonance Imaging | 27 | 2023 | 3737 | 0.520 |
Why?
| | Ascites | 2 | 2016 | 47 | 0.520 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2017 | 68 | 0.520 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2021 | 134 | 0.510 |
Why?
| | Aged | 64 | 2026 | 24754 | 0.500 |
Why?
| | Stents | 8 | 2015 | 531 | 0.500 |
Why?
| | Tomography, X-Ray Computed | 25 | 2026 | 2765 | 0.500 |
Why?
| | Orthopedic Procedures | 1 | 2019 | 229 | 0.500 |
Why?
| | Retrospective Studies | 37 | 2023 | 16375 | 0.490 |
Why?
| | Digestive System Neoplasms | 1 | 2015 | 9 | 0.470 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2016 | 34 | 0.470 |
Why?
| | Aged, 80 and over | 34 | 2021 | 7924 | 0.470 |
Why?
| | Brachytherapy | 8 | 2008 | 131 | 0.460 |
Why?
| | Male | 88 | 2026 | 70193 | 0.460 |
Why?
| | Cholestasis | 2 | 2015 | 209 | 0.450 |
Why?
| | Adult | 59 | 2021 | 39407 | 0.440 |
Why?
| | Social Media | 1 | 2017 | 161 | 0.440 |
Why?
| | United States | 17 | 2026 | 15310 | 0.440 |
Why?
| | Radiology | 2 | 2024 | 171 | 0.420 |
Why?
| | Radiation Dosage | 6 | 2020 | 191 | 0.410 |
Why?
| | Liver Neoplasms, Experimental | 4 | 2020 | 26 | 0.380 |
Why?
| | Thrombosis | 4 | 2022 | 399 | 0.380 |
Why?
| | Clinical Competence | 2 | 2019 | 1205 | 0.370 |
Why?
| | Ovary | 3 | 2003 | 225 | 0.370 |
Why?
| | Imaging, Three-Dimensional | 5 | 2011 | 569 | 0.350 |
Why?
| | Angiography | 11 | 2011 | 207 | 0.350 |
Why?
| | Liver Cirrhosis | 6 | 2019 | 282 | 0.350 |
Why?
| | Risk Factors | 18 | 2020 | 10483 | 0.340 |
Why?
| | Uterine Artery Embolization | 1 | 2010 | 8 | 0.330 |
Why?
| | Vascular System Injuries | 3 | 2016 | 76 | 0.320 |
Why?
| | Cholangiocarcinoma | 4 | 2013 | 96 | 0.320 |
Why?
| | Perfusion Imaging | 1 | 2010 | 62 | 0.320 |
Why?
| | Drainage | 3 | 2019 | 176 | 0.320 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2021 | 232 | 0.320 |
Why?
| | Angioplasty | 3 | 2007 | 47 | 0.320 |
Why?
| | Chicago | 6 | 2017 | 61 | 0.320 |
Why?
| | Adenoma, Islet Cell | 1 | 2009 | 6 | 0.320 |
Why?
| | Aortic Aneurysm, Abdominal | 3 | 2007 | 162 | 0.310 |
Why?
| | Liver Abscess | 1 | 2009 | 5 | 0.310 |
Why?
| | Thyroid Gland | 1 | 2009 | 92 | 0.300 |
Why?
| | Predictive Value of Tests | 11 | 2020 | 2075 | 0.300 |
Why?
| | Observer Variation | 3 | 2010 | 357 | 0.300 |
Why?
| | Polyvinyl Alcohol | 3 | 2005 | 18 | 0.300 |
Why?
| | Hepatic Veins | 1 | 2008 | 31 | 0.290 |
Why?
| | Neoplasms | 5 | 2023 | 2747 | 0.290 |
Why?
| | Phlebography | 6 | 2015 | 37 | 0.290 |
Why?
| | Rabbits | 12 | 2020 | 754 | 0.290 |
Why?
| | Contrast Media | 12 | 2016 | 470 | 0.290 |
Why?
| | Neovascularization, Pathologic | 5 | 2009 | 296 | 0.280 |
Why?
| | Portography | 4 | 2016 | 7 | 0.280 |
Why?
| | Gelatin | 2 | 2005 | 57 | 0.280 |
Why?
| | Liver Transplantation | 5 | 2015 | 768 | 0.270 |
Why?
| | Lymphangioma, Cystic | 1 | 2007 | 5 | 0.270 |
Why?
| | Patient Selection | 6 | 2020 | 688 | 0.260 |
Why?
| | Databases, Factual | 7 | 2020 | 1448 | 0.260 |
Why?
| | Prosthesis Failure | 3 | 2017 | 125 | 0.260 |
Why?
| | Catheterization | 7 | 2013 | 182 | 0.260 |
Why?
| | Aortography | 1 | 2007 | 54 | 0.260 |
Why?
| | Pancreatic Neoplasms | 3 | 2010 | 890 | 0.260 |
Why?
| | Antineoplastic Agents | 6 | 2014 | 2169 | 0.260 |
Why?
| | Hepatic Artery | 5 | 2010 | 52 | 0.250 |
Why?
| | Logistic Models | 8 | 2021 | 2092 | 0.250 |
Why?
| | Referral and Consultation | 1 | 2012 | 799 | 0.250 |
Why?
| | Linear Models | 4 | 2017 | 858 | 0.250 |
Why?
| | Thrombolytic Therapy | 4 | 2023 | 155 | 0.250 |
Why?
| | Bile Duct Neoplasms | 4 | 2013 | 118 | 0.250 |
Why?
| | Thyroid Neoplasms | 1 | 2009 | 327 | 0.240 |
Why?
| | Acrylic Resins | 1 | 2005 | 47 | 0.230 |
Why?
| | Radiation Injuries | 5 | 2010 | 149 | 0.230 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2007 | 222 | 0.220 |
Why?
| | Blister | 1 | 2004 | 40 | 0.220 |
Why?
| | Arteries | 7 | 2013 | 263 | 0.210 |
Why?
| | Multivariate Analysis | 7 | 2017 | 1498 | 0.210 |
Why?
| | Prospective Studies | 17 | 2026 | 7777 | 0.210 |
Why?
| | Survival Rate | 12 | 2018 | 1972 | 0.210 |
Why?
| | Cohort Studies | 7 | 2023 | 5815 | 0.210 |
Why?
| | Internship and Residency | 2 | 2019 | 1240 | 0.210 |
Why?
| | Postphlebitic Syndrome | 1 | 2023 | 2 | 0.200 |
Why?
| | Postthrombotic Syndrome | 1 | 2023 | 13 | 0.200 |
Why?
| | Jugular Veins | 3 | 1997 | 42 | 0.200 |
Why?
| | Neoplasm Staging | 8 | 2014 | 1401 | 0.190 |
Why?
| | Fluoroscopy | 2 | 2016 | 169 | 0.190 |
Why?
| | Elasticity Imaging Techniques | 1 | 2022 | 58 | 0.190 |
Why?
| | Catheters | 3 | 2023 | 74 | 0.180 |
Why?
| | Education, Medical, Continuing | 2 | 2017 | 133 | 0.180 |
Why?
| | Neoplasms, Experimental | 2 | 2013 | 174 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 9 | 2015 | 910 | 0.180 |
Why?
| | Clinical Trials as Topic | 3 | 2013 | 1057 | 0.180 |
Why?
| | Chi-Square Distribution | 6 | 2014 | 521 | 0.180 |
Why?
| | Disease Progression | 14 | 2014 | 2801 | 0.180 |
Why?
| | Liver | 7 | 2013 | 1820 | 0.180 |
Why?
| | Constriction, Pathologic | 3 | 2019 | 241 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 363 | 0.170 |
Why?
| | Vascular Patency | 3 | 2018 | 109 | 0.170 |
Why?
| | Bone-Implant Interface | 1 | 2021 | 3 | 0.170 |
Why?
| | Angiography, Digital Subtraction | 6 | 2014 | 46 | 0.170 |
Why?
| | Ultrasonography, Doppler, Color | 3 | 2008 | 37 | 0.170 |
Why?
| | Reoperation | 4 | 2019 | 592 | 0.170 |
Why?
| | Catheter Ablation | 1 | 2004 | 313 | 0.170 |
Why?
| | Early Detection of Cancer | 1 | 2026 | 444 | 0.170 |
Why?
| | alpha-Fetoproteins | 2 | 2012 | 40 | 0.170 |
Why?
| | Surgical Stomas | 1 | 2000 | 7 | 0.170 |
Why?
| | Medical Oncology | 2 | 2013 | 317 | 0.170 |
Why?
| | Colostomy | 1 | 2000 | 28 | 0.160 |
Why?
| | Disease Models, Animal | 6 | 2016 | 4421 | 0.160 |
Why?
| | Liver Diseases | 2 | 2007 | 301 | 0.160 |
Why?
| | Varicose Veins | 1 | 2000 | 16 | 0.160 |
Why?
| | Adolescent | 16 | 2021 | 22138 | 0.160 |
Why?
| | Infusions, Intra-Arterial | 9 | 2010 | 61 | 0.160 |
Why?
| | Sensitivity and Specificity | 9 | 2012 | 1978 | 0.160 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2020 | 110 | 0.160 |
Why?
| | Costs and Cost Analysis | 1 | 2020 | 222 | 0.160 |
Why?
| | Lumbosacral Region | 1 | 2020 | 62 | 0.160 |
Why?
| | Budd-Chiari Syndrome | 1 | 1999 | 5 | 0.150 |
Why?
| | Hepatorenal Syndrome | 1 | 2019 | 15 | 0.150 |
Why?
| | Laminoplasty | 1 | 2019 | 2 | 0.150 |
Why?
| | Laminectomy | 1 | 2019 | 32 | 0.150 |
Why?
| | Follow-Up Studies | 11 | 2013 | 5214 | 0.150 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2011 | 278 | 0.150 |
Why?
| | Hemorrhage | 2 | 2023 | 760 | 0.150 |
Why?
| | Specialization | 1 | 2020 | 130 | 0.150 |
Why?
| | Bile Ducts | 1 | 2019 | 67 | 0.150 |
Why?
| | Ohio | 1 | 2019 | 140 | 0.150 |
Why?
| | Iliac Artery | 2 | 2018 | 57 | 0.150 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 149 | 0.150 |
Why?
| | Glass | 3 | 2013 | 46 | 0.150 |
Why?
| | Models, Educational | 1 | 2019 | 95 | 0.140 |
Why?
| | Survival Analysis | 6 | 2011 | 1320 | 0.140 |
Why?
| | Young Adult | 8 | 2021 | 13751 | 0.140 |
Why?
| | Biliary Fistula | 1 | 1998 | 4 | 0.140 |
Why?
| | Urinary Fistula | 1 | 1998 | 9 | 0.140 |
Why?
| | Intestine, Small | 1 | 2019 | 157 | 0.140 |
Why?
| | Diffusion Magnetic Resonance Imaging | 2 | 2010 | 156 | 0.140 |
Why?
| | Mesenteric Veins | 1 | 1998 | 23 | 0.140 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2021 | 265 | 0.140 |
Why?
| | Fibrin | 2 | 2023 | 91 | 0.140 |
Why?
| | Pain | 1 | 2003 | 781 | 0.140 |
Why?
| | Writing | 1 | 2019 | 101 | 0.140 |
Why?
| | Thrombectomy | 1 | 1998 | 75 | 0.130 |
Why?
| | Liver Circulation | 4 | 2015 | 11 | 0.130 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 212 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2026 | 2938 | 0.130 |
Why?
| | Radiography | 7 | 2012 | 844 | 0.130 |
Why?
| | Treatment Failure | 4 | 2017 | 355 | 0.130 |
Why?
| | Patient Advocacy | 1 | 2017 | 76 | 0.130 |
Why?
| | Drug Utilization | 1 | 2017 | 169 | 0.130 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 22 | 0.120 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 27 | 0.120 |
Why?
| | Portal Pressure | 1 | 2016 | 4 | 0.120 |
Why?
| | History, 20th Century | 1 | 2017 | 330 | 0.120 |
Why?
| | Severity of Illness Index | 2 | 2021 | 2911 | 0.120 |
Why?
| | Hospitals | 1 | 2021 | 696 | 0.120 |
Why?
| | Anatomic Landmarks | 1 | 2016 | 30 | 0.120 |
Why?
| | Balloon Occlusion | 1 | 2016 | 36 | 0.120 |
Why?
| | Academic Medical Centers | 1 | 2019 | 531 | 0.120 |
Why?
| | Finite Element Analysis | 1 | 2016 | 75 | 0.120 |
Why?
| | Gadolinium DTPA | 5 | 2014 | 71 | 0.120 |
Why?
| | Research Design | 3 | 2013 | 1146 | 0.120 |
Why?
| | Lower Extremity | 1 | 2020 | 439 | 0.120 |
Why?
| | Doxorubicin | 3 | 2013 | 360 | 0.120 |
Why?
| | Cell Line, Tumor | 7 | 2013 | 3495 | 0.120 |
Why?
| | Patient Readmission | 1 | 2021 | 708 | 0.120 |
Why?
| | Stomach | 2 | 2013 | 110 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2016 | 86 | 0.120 |
Why?
| | Operative Time | 1 | 2016 | 154 | 0.120 |
Why?
| | Reproducibility of Results | 8 | 2011 | 3358 | 0.120 |
Why?
| | Radiation Exposure | 1 | 2016 | 55 | 0.120 |
Why?
| | Biomarkers, Tumor | 4 | 2026 | 1258 | 0.120 |
Why?
| | Aorta | 1 | 2018 | 424 | 0.120 |
Why?
| | Bile Ducts, Intrahepatic | 3 | 2013 | 58 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 4 | 2000 | 307 | 0.110 |
Why?
| | Hospital Mortality | 2 | 2018 | 924 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2016 | 148 | 0.110 |
Why?
| | Necrosis | 5 | 2020 | 249 | 0.110 |
Why?
| | Dilatation | 1 | 2015 | 69 | 0.110 |
Why?
| | Sex Factors | 2 | 2018 | 2063 | 0.110 |
Why?
| | Biopsy | 3 | 2014 | 1083 | 0.110 |
Why?
| | Carotid Artery Injuries | 3 | 2000 | 40 | 0.110 |
Why?
| | Cisplatin | 3 | 2012 | 327 | 0.110 |
Why?
| | Data Interpretation, Statistical | 3 | 2013 | 377 | 0.110 |
Why?
| | Foreign-Body Migration | 1 | 2014 | 32 | 0.110 |
Why?
| | Wounds, Gunshot | 1 | 1998 | 248 | 0.110 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 526 | 0.110 |
Why?
| | Length of Stay | 2 | 2019 | 1263 | 0.110 |
Why?
| | Carbon Dioxide | 1 | 2016 | 243 | 0.110 |
Why?
| | Kidney Diseases | 1 | 1998 | 409 | 0.100 |
Why?
| | Stress, Mechanical | 1 | 2016 | 489 | 0.100 |
Why?
| | Magnetite Nanoparticles | 1 | 2013 | 28 | 0.100 |
Why?
| | Duodenum | 1 | 2013 | 74 | 0.100 |
Why?
| | Anticoagulants | 2 | 2017 | 675 | 0.100 |
Why?
| | Ultrasonography | 3 | 2022 | 761 | 0.100 |
Why?
| | Peripheral Arterial Disease | 1 | 2020 | 490 | 0.100 |
Why?
| | Arthroscopy | 3 | 1992 | 245 | 0.100 |
Why?
| | Prevalence | 3 | 2021 | 2799 | 0.100 |
Why?
| | Catheterization, Peripheral | 3 | 2008 | 108 | 0.100 |
Why?
| | Regional Blood Flow | 3 | 2007 | 498 | 0.100 |
Why?
| | Patient Education as Topic | 1 | 2017 | 778 | 0.090 |
Why?
| | Biomechanical Phenomena | 1 | 2016 | 839 | 0.090 |
Why?
| | Proportional Hazards Models | 5 | 2014 | 1268 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2026 | 2567 | 0.090 |
Why?
| | Shoulder Injuries | 1 | 1992 | 59 | 0.090 |
Why?
| | Acromion | 1 | 1992 | 8 | 0.090 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 1793 | 0.090 |
Why?
| | Electroporation | 1 | 2012 | 38 | 0.090 |
Why?
| | Tendon Injuries | 1 | 1992 | 67 | 0.090 |
Why?
| | Respiratory-Gated Imaging Techniques | 1 | 2011 | 10 | 0.090 |
Why?
| | Fibromuscular Dysplasia | 1 | 2011 | 9 | 0.090 |
Why?
| | Rotator Cuff | 1 | 1992 | 47 | 0.090 |
Why?
| | Comorbidity | 1 | 2016 | 1664 | 0.080 |
Why?
| | Animals | 15 | 2021 | 37748 | 0.080 |
Why?
| | Prognosis | 5 | 2010 | 4084 | 0.080 |
Why?
| | Yttrium | 1 | 2010 | 5 | 0.080 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 79 | 0.080 |
Why?
| | Injections, Intra-Arterial | 5 | 2012 | 26 | 0.080 |
Why?
| | Research Report | 1 | 2011 | 86 | 0.080 |
Why?
| | Tumor Burden | 3 | 2020 | 312 | 0.080 |
Why?
| | Neuroendocrine Tumors | 1 | 2011 | 110 | 0.080 |
Why?
| | Punctures | 1 | 2010 | 39 | 0.080 |
Why?
| | Practice Guidelines as Topic | 5 | 2013 | 1570 | 0.080 |
Why?
| | Decision Support Techniques | 1 | 2014 | 431 | 0.080 |
Why?
| | Biopsy, Fine-Needle | 1 | 2009 | 70 | 0.080 |
Why?
| | Gastrostomy | 2 | 2009 | 122 | 0.080 |
Why?
| | Recurrence | 3 | 2021 | 1112 | 0.080 |
Why?
| | Pancreatic Pseudocyst | 1 | 2009 | 17 | 0.080 |
Why?
| | Bilirubin | 3 | 2010 | 90 | 0.070 |
Why?
| | Breast Neoplasms | 2 | 2014 | 2257 | 0.070 |
Why?
| | Liver Function Tests | 3 | 2015 | 105 | 0.070 |
Why?
| | Radiation Pneumonitis | 1 | 2008 | 31 | 0.070 |
Why?
| | Ambulatory Care Facilities | 1 | 2010 | 248 | 0.070 |
Why?
| | Biliary Tract | 1 | 2008 | 14 | 0.070 |
Why?
| | Radiotherapy Dosage | 4 | 2010 | 281 | 0.070 |
Why?
| | Knee Injuries | 1 | 1989 | 101 | 0.070 |
Why?
| | Maximum Allowable Concentration | 1 | 2007 | 16 | 0.070 |
Why?
| | Palliative Care | 1 | 2015 | 822 | 0.070 |
Why?
| | Subtraction Technique | 1 | 2007 | 25 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 250 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2009 | 1504 | 0.070 |
Why?
| | Endpoint Determination | 3 | 2013 | 78 | 0.070 |
Why?
| | Vacuum Curettage | 1 | 2007 | 5 | 0.070 |
Why?
| | Acute Disease | 2 | 2021 | 1010 | 0.070 |
Why?
| | Ultrasonography, Doppler, Duplex | 2 | 2004 | 39 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2008 | 178 | 0.070 |
Why?
| | Incidence | 3 | 2009 | 2806 | 0.070 |
Why?
| | Image Enhancement | 4 | 2011 | 191 | 0.060 |
Why?
| | Radiotherapy | 1 | 2008 | 208 | 0.060 |
Why?
| | Leiomyomatosis | 1 | 2006 | 4 | 0.060 |
Why?
| | Credentialing | 1 | 2006 | 21 | 0.060 |
Why?
| | Catheterization, Central Venous | 2 | 1999 | 116 | 0.060 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 288 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 333 | 0.060 |
Why?
| | Iron | 1 | 2008 | 324 | 0.060 |
Why?
| | France | 1 | 2026 | 39 | 0.060 |
Why?
| | Fluorescent Dyes | 1 | 2007 | 324 | 0.060 |
Why?
| | Ethics, Research | 1 | 2005 | 34 | 0.060 |
Why?
| | Personnel Selection | 1 | 2006 | 87 | 0.060 |
Why?
| | Hospitalization | 3 | 2021 | 2264 | 0.060 |
Why?
| | Knee Joint | 1 | 1989 | 411 | 0.060 |
Why?
| | Heart Failure | 1 | 2018 | 2093 | 0.060 |
Why?
| | Organ Size | 3 | 2013 | 481 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2011 | 678 | 0.060 |
Why?
| | Postmenopause | 1 | 2007 | 371 | 0.060 |
Why?
| | Decision Making | 1 | 2012 | 961 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2020 | 119 | 0.060 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1249 | 0.050 |
Why?
| | Odds Ratio | 2 | 2017 | 1057 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 3 | 2008 | 144 | 0.050 |
Why?
| | Analgesia, Patient-Controlled | 1 | 2003 | 16 | 0.050 |
Why?
| | Pilot Projects | 4 | 2009 | 1826 | 0.050 |
Why?
| | Ischemia | 1 | 2006 | 415 | 0.050 |
Why?
| | Iliac Vein | 1 | 2023 | 14 | 0.050 |
Why?
| | Illinois | 3 | 2009 | 44 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2006 | 323 | 0.050 |
Why?
| | Femoral Vein | 1 | 2023 | 35 | 0.050 |
Why?
| | Aneurysm, False | 2 | 2000 | 45 | 0.050 |
Why?
| | Menisci, Tibial | 2 | 1995 | 62 | 0.050 |
Why?
| | Watchful Waiting | 1 | 2023 | 85 | 0.050 |
Why?
| | Elasticity | 1 | 2022 | 194 | 0.050 |
Why?
| | Pelvis | 1 | 2002 | 115 | 0.040 |
Why?
| | Drug Stability | 2 | 2013 | 166 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 805 | 0.040 |
Why?
| | Hepatectomy | 2 | 2013 | 250 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2013 | 329 | 0.040 |
Why?
| | Feasibility Studies | 3 | 2011 | 1027 | 0.040 |
Why?
| | World Health Organization | 2 | 2012 | 126 | 0.040 |
Why?
| | X-Ray Microtomography | 1 | 2021 | 99 | 0.040 |
Why?
| | Osseointegration | 1 | 2021 | 71 | 0.040 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2021 | 60 | 0.040 |
Why?
| | Europe | 2 | 2012 | 412 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 614 | 0.040 |
Why?
| | Allografts | 1 | 2021 | 147 | 0.040 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 367 | 0.040 |
Why?
| | Carotid Artery, Internal | 1 | 2000 | 44 | 0.040 |
Why?
| | Neural Crest | 1 | 2021 | 121 | 0.040 |
Why?
| | Cardiologists | 1 | 2020 | 45 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2013 | 718 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 52 | 0.040 |
Why?
| | Skull | 1 | 2021 | 151 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2021 | 327 | 0.040 |
Why?
| | Hepatic Encephalopathy | 1 | 1999 | 25 | 0.040 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2020 | 75 | 0.040 |
Why?
| | Menstrual Cycle | 1 | 2000 | 134 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 600 | 0.040 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 750 | 0.040 |
Why?
| | Tomography, Emission-Computed | 2 | 2009 | 68 | 0.040 |
Why?
| | Tracheoesophageal Fistula | 1 | 1999 | 33 | 0.040 |
Why?
| | Liver Failure | 1 | 1999 | 80 | 0.040 |
Why?
| | Anastomosis, Surgical | 1 | 2019 | 159 | 0.040 |
Why?
| | Streptokinase | 1 | 1998 | 9 | 0.040 |
Why?
| | Multiple Organ Failure | 1 | 1999 | 127 | 0.040 |
Why?
| | Serum Albumin | 1 | 1999 | 153 | 0.040 |
Why?
| | Analysis of Variance | 2 | 2011 | 1321 | 0.040 |
Why?
| | Equipment Design | 2 | 2012 | 525 | 0.040 |
Why?
| | Ethiodized Oil | 2 | 2008 | 9 | 0.040 |
Why?
| | Postoperative Hemorrhage | 1 | 1999 | 89 | 0.040 |
Why?
| | Mitomycin | 2 | 2008 | 33 | 0.040 |
Why?
| | Swine | 2 | 2016 | 812 | 0.040 |
Why?
| | Guidelines as Topic | 2 | 2010 | 275 | 0.030 |
Why?
| | Population Surveillance | 1 | 2001 | 482 | 0.030 |
Why?
| | Nervous System Diseases | 2 | 2017 | 277 | 0.030 |
Why?
| | Cartilage Diseases | 2 | 1995 | 45 | 0.030 |
Why?
| | Intracranial Hypertension | 1 | 1997 | 42 | 0.030 |
Why?
| | Cause of Death | 1 | 1999 | 441 | 0.030 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1997 | 128 | 0.030 |
Why?
| | Abdominal Injuries | 1 | 1998 | 122 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 1997 | 179 | 0.030 |
Why?
| | Demography | 1 | 2017 | 296 | 0.030 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1997 | 142 | 0.030 |
Why?
| | Positron-Emission Tomography | 2 | 2008 | 310 | 0.030 |
Why?
| | Databases as Topic | 2 | 2010 | 69 | 0.030 |
Why?
| | Recovery of Function | 1 | 2000 | 684 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2003 | 3597 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 1998 | 284 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 587 | 0.030 |
Why?
| | Surgeons | 1 | 2020 | 336 | 0.030 |
Why?
| | Lung | 1 | 2008 | 4142 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2016 | 197 | 0.030 |
Why?
| | Inpatients | 1 | 2019 | 512 | 0.030 |
Why?
| | Phantoms, Imaging | 2 | 2008 | 150 | 0.030 |
Why?
| | Cysts | 1 | 1995 | 114 | 0.030 |
Why?
| | Embolism | 2 | 2008 | 43 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 532 | 0.030 |
Why?
| | Preoperative Care | 1 | 2016 | 372 | 0.030 |
Why?
| | Ablation Techniques | 1 | 2013 | 34 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2021 | 2006 | 0.020 |
Why?
| | Vascular Surgical Procedures | 1 | 2016 | 333 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2013 | 68 | 0.020 |
Why?
| | Scapula | 1 | 1992 | 44 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 219 | 0.020 |
Why?
| | Nausea | 1 | 2011 | 111 | 0.020 |
Why?
| | Muscular Diseases | 1 | 1992 | 113 | 0.020 |
Why?
| | Vomiting | 1 | 2011 | 129 | 0.020 |
Why?
| | International Agencies | 1 | 2010 | 33 | 0.020 |
Why?
| | Biomarkers | 2 | 2014 | 4191 | 0.020 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2010 | 76 | 0.020 |
Why?
| | Diarrhea | 1 | 2011 | 184 | 0.020 |
Why?
| | Abdominal Pain | 1 | 2011 | 145 | 0.020 |
Why?
| | Standard of Care | 1 | 2010 | 77 | 0.020 |
Why?
| | Neoadjuvant Therapy | 1 | 2013 | 424 | 0.020 |
Why?
| | Risk Assessment | 2 | 2009 | 3508 | 0.020 |
Why?
| | Yttrium Isotopes | 1 | 2009 | 1 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2010 | 149 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2010 | 328 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2021 | 5697 | 0.020 |
Why?
| | Fatigue | 1 | 2011 | 339 | 0.020 |
Why?
| | Registries | 1 | 2018 | 2144 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 3294 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 1992 | 414 | 0.020 |
Why?
| | Chronic Disease | 1 | 2015 | 1822 | 0.020 |
Why?
| | Fibula | 1 | 1989 | 41 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 244 | 0.020 |
Why?
| | Ligaments, Articular | 1 | 1989 | 54 | 0.020 |
Why?
| | ROC Curve | 1 | 2010 | 590 | 0.020 |
Why?
| | Rhenium | 1 | 2008 | 3 | 0.020 |
Why?
| | Radioisotopes | 1 | 2008 | 36 | 0.020 |
Why?
| | Iohexol | 1 | 2008 | 22 | 0.020 |
Why?
| | Body Burden | 1 | 2007 | 8 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 330 | 0.020 |
Why?
| | Hysterosalpingography | 1 | 2007 | 6 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2013 | 2525 | 0.020 |
Why?
| | Tibia | 1 | 1989 | 183 | 0.020 |
Why?
| | Regression Analysis | 1 | 2010 | 1023 | 0.020 |
Why?
| | Hindlimb | 1 | 2008 | 134 | 0.020 |
Why?
| | Injections | 1 | 2008 | 191 | 0.020 |
Why?
| | Mesenteric Arteries | 1 | 2007 | 17 | 0.020 |
Why?
| | Celiac Artery | 1 | 2007 | 20 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2007 | 131 | 0.020 |
Why?
| | Femur | 1 | 1989 | 260 | 0.020 |
Why?
| | Contraindications | 1 | 2007 | 85 | 0.020 |
Why?
| | Injury Severity Score | 2 | 2000 | 560 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 962 | 0.020 |
Why?
| | Weight Loss | 1 | 2011 | 791 | 0.020 |
Why?
| | Retreatment | 1 | 2005 | 73 | 0.010 |
Why?
| | Cartilage, Articular | 1 | 1989 | 331 | 0.010 |
Why?
| | Rats | 1 | 2013 | 5637 | 0.010 |
Why?
| | Neoplasm Metastasis | 1 | 2007 | 676 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2010 | 1634 | 0.010 |
Why?
| | Algorithms | 1 | 2011 | 1769 | 0.010 |
Why?
| | Mice | 1 | 2021 | 18108 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11512 | 0.010 |
Why?
| | Child | 3 | 2017 | 22413 | 0.010 |
Why?
| | Radiography, Abdominal | 1 | 2001 | 44 | 0.010 |
Why?
| | Blood Flow Velocity | 1 | 2002 | 412 | 0.010 |
Why?
| | Models, Animal | 1 | 2002 | 396 | 0.010 |
Why?
| | Arteriosclerosis | 1 | 2000 | 83 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2000 | 48 | 0.010 |
Why?
| | Pneumonia, Aspiration | 1 | 1999 | 17 | 0.010 |
Why?
| | Hematoma | 1 | 1999 | 54 | 0.010 |
Why?
| | Veins | 1 | 1999 | 70 | 0.010 |
Why?
| | Aortic Diseases | 1 | 2000 | 119 | 0.010 |
Why?
| | Esophageal Stenosis | 1 | 1999 | 56 | 0.010 |
Why?
| | Endoscopy | 1 | 2001 | 324 | 0.010 |
Why?
| | Intubation, Gastrointestinal | 1 | 1999 | 77 | 0.010 |
Why?
| | Decision Trees | 1 | 1998 | 82 | 0.010 |
Why?
| | Arm | 1 | 1999 | 108 | 0.010 |
Why?
| | Peripheral Nervous System Diseases | 1 | 1999 | 132 | 0.010 |
Why?
| | Cerebral Infarction | 1 | 1997 | 50 | 0.010 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 68 | 0.010 |
Why?
| | Los Angeles | 1 | 1997 | 75 | 0.010 |
Why?
| | Carotid Artery Diseases | 1 | 1997 | 62 | 0.010 |
Why?
| | Neurologic Examination | 1 | 1997 | 128 | 0.010 |
Why?
| | Intracranial Pressure | 1 | 1997 | 60 | 0.010 |
Why?
| | Clinical Protocols | 1 | 1998 | 273 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 1999 | 202 | 0.010 |
Why?
| | Glasgow Coma Scale | 1 | 1997 | 204 | 0.010 |
Why?
| | Multiple Trauma | 1 | 1997 | 113 | 0.010 |
Why?
| | Carotid Stenosis | 1 | 1997 | 97 | 0.010 |
Why?
| | Angioplasty, Balloon | 1 | 1997 | 93 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1997 | 201 | 0.010 |
Why?
| | HIV | 1 | 1997 | 250 | 0.010 |
Why?
| | Heparin | 1 | 1997 | 259 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 1997 | 339 | 0.010 |
Why?
| | Cluster Analysis | 1 | 1997 | 521 | 0.010 |
Why?
| | Synovial Cyst | 1 | 1995 | 5 | 0.010 |
Why?
| | Craniocerebral Trauma | 1 | 1997 | 170 | 0.010 |
Why?
| | DNA, Viral | 1 | 1997 | 367 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1997 | 320 | 0.010 |
Why?
| | Brain Ischemia | 1 | 1997 | 350 | 0.010 |
Why?
| | Brain Injuries | 1 | 1997 | 502 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2002 | 5974 | 0.000 |
Why?
| | Tibial Meniscus Injuries | 1 | 1990 | 49 | 0.000 |
Why?
| | Postoperative Period | 1 | 1990 | 361 | 0.000 |
Why?
|
|
Ryu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|